Last reviewed · How we verify
severe asthma
Approved treatments
- Exdensur · Glaxosmithkline Llc
Exdensur works by binding to histamine, preventing it from interacting with its receptors and reducing inflammation and airway constriction. - Tezspire · AstraZeneca
Tezspire blocks the action of Thymic Stromal Lymphopoietin (TSLP), a protein that triggers inflammation in the airways. - TEZSPIRE · ASTRAZENECA AB
- Tezspire · Qilu Pharmaceutical Co., Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- severe asthma patent landscape — cliff calendar, originator estates, attackable patents
- severe asthma treatment landscape brief
- severe asthma treatment updates RSS
Frequently asked questions about severe asthma
What drugs treat severe asthma?
Tracked treatments include Exdensur, Tezspire, TEZSPIRE.
What is the treatment for severe asthma?
Standard treatment for severe asthma includes Exdensur, Tezspire, TEZSPIRE. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: severe asthma patent cliff · severe asthma CI report
- Treatment: Exdensur · Glaxosmithkline Llc
- Treatment: Tezspire · AstraZeneca
- Treatment: TEZSPIRE · ASTRAZENECA AB
- Treatment: Tezspire · Qilu Pharmaceutical Co., Ltd.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing